Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-b*2705 transgenic CBA (H-2(k)) mice

Arthritis and Rheumatism

Volumn 40, Issue 5, 1997, Pages 945-954

  Kuon, Wolfgang ^a   Lauster, Roland ^b   Böttcher, Ute ^a   Koroknay, Armin ^c   Ulbrecht, Matthias ^c   Hartmann, Matthias ^d   Grolms, Martina ^a   Ugrinovic, Sanja ^a   Braun, Jürgen ^a   Weiss, Elisabeth H ^c   Sieper, Joachim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BETA 2 MICROGLOBULIN; HLA B27 ANTIGEN; MONOCLONAL ANTIBODY;

ADOLESCENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REACTIVE ARTHRITIS; TRANSGENIC MOUSE;

EID: 0030941925     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400524     Document Type: Article

References (62)

1. Brewerton DA, Hart FD, Caffrey M, Nichols A, James DCO, Sturrock RD: Ankylosing spondylitis and HLA-A27. Lancet 1:904-907, 1973
2. Sieper J, Braun J: Pathogenesis of spondylarthropathies: persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum 38: 1547-1554, 1995
3. Sieper J, Kingsley G: Recent advances in the pathogenesis of reactive arthritis. Immunol Today 17:160-163, 1996
4. 2m: an animal model of HLA-B27 associated human disorders. Cell 63:1099-1112, 1993
5. Breban M, Hammer RE, Richardson JA, Taurog JD: Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med 178:1607-1616, 1993
6. Taurog JD, Maika SD, Simmons WA, Breban M, Hammer RE: Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 150:4168-4178, 1993
7. Burmester GR, Daser A, Kamradt T, Krause A, Mitchison NA, Sieper J, Wolf N: Immunology of reactive arthritis. Annu Rev Immunol 13:229-250, 1995
8. Hermann E, Yu DTY, Meyer zum Büschenfelde KH, Fleischer B: HLA-B27-restricted CDS T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 342:646-650, 1993
9. Kingsley G, Sieper J: Current perspectives in reactive arthritis. Immunol Today 14:387-391, 1993
10. Ward ME: Chlamydial classification, development and structure. Br Med Bull 39:109-115, 1983
11. Schachter J: The intracellular life of Chlamydia. Curr Top Microbiol Immunol 138:109-139, 1988
12. Moulder JW: Interaction of Chlamydia with immune cells and immune molecules in vitro. Microbiol Rev 55:143-189, 1991
13. Germain RN: MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287-299, 1994
14. Pfeifer JD, Wick MJ, Roberts L, Finlay K, Normark SJ, Harding CV: Phagocytic processing of bacterial antigens for class I MHC presentation to cells. Nature 361:359-362, 1993
15. Rock KL, Rothstein L, Gamble S, Fleischacher C: Characterization of antigen-presenting cells that express exogenous antigens in association with class I MHC molecules. J Immunol 150:438-446, 1993
16. Harding CV, Song R: Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class 1 MHC molecules. J Immunol 153:4925-4933, 1994
17. De Bruijn MLH, Jackson MR, Peterson PA: Phagocyte-induced antigen-specific activation of unprimed CD8+ T cells in vitro. Eur J Immunol 25:1274-1285, 1995
18. Kaufmann SHE: Immunity to intracellular bacteria. Annu Rev Immunol 11:129-163, 1993
19. Kievits F, Ivanyi P, Krimpenford P, Berns A, Ploegh HL: HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature 329:447-449, 1987
20. Dill O, Kievits F, Koch S, Ivanyi P, Hämmerling GH: Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice. Proc Natl Acad Sci U S A 85:5664-5668, 1988
21. 2-microglobulin control cell surface expression of HLA-B27 in transgenic mice with a 25 kb B27 gene fragment. In, Transgenic Mice and Mutants in MHC Research, Edited by IK Egorov, CS David. Berlin, Springer Verlag, 1990
22. Morrison RP, Belland RJ, Lyng KL, Caldwell HD: Chlamydial disease pathogenesis: the 57 kD Chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 170:1271-1283, 1989
23. Morrison RP, Lyng K, Caldwell HD: Chlamydial disease pathogenesis: ocular hypersensitivity elicited by a genus specific 57-kD protein. J Exp Med 169:663-675, 1989
24. Weiss EH, Kuon W, Dörner C, Lang M, Riethmüller G: Organization, sequence and expression of the HLA-B27 gene: a molecular approach to analyze HLA and disease associations. Immunobiology 170:367-380, 1985
25. Weiss EH, Bloemer K, Doerner C, Kuon W, Lang M, Pohla H, Schattenkirchner M, Riethmüller G: Molecular biology of the HLA-B27 locus. Br J Rheumatol 27 (suppl II):12-18, 1988
26. 2-microglobulin) chains of HLA class I antigens. EMBO J 6:1673-1676, 1987
27. 2-microglobulin: selection by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A 80:524-528, 1983
28. Koren HS, Handwerger BS, Wunderlich JR: Identification of macrophage-like characteristics in a cultured murine tumor line. J Immunol 114:894-897, 1975
29. Grosfeld FG, Lund T, Murray EJ, Mellor AL, Dahl HHM, Flavell RA: The construction of cosmid libraries which can be used to transform eucaryotic cells. Nucleic Acids Res 10:6715-6732, 1982
30. Qin S, Wise M, Cobbold SP, Leong L, Kong YCM, Parnes JR, Waldmann H: Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 20: 2737-2745, 1990
31. Moore AE, Sabachewsky L, Toolan HW: Culture characteristics of four permanent lines of human cancer cells. Cancer Res 15:598-602, 1955
32. Moore M, Carbon R, Bevan M: Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777-785, 1988
33. Pavia CS, Schachter J: Failure to detect cell-mediated cytotoxicity against Chlamydia trachomatis-infected cells. Infect Immun 39: 1271-1274, 1983
34. Lammert JK: Cylotoxic cells induced after Chlamydia psittaci infection in mice. Infect Immun 35:1011-1017, 1982
35. Beatty PR, Stephens RS: CD8+ T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway. J Immunol 153:4588-4595, 1994
36. Magee DL, Williams DM, Smith JG, Bleicker CA, Grubbs BG, Schachter J, Rank RG: Role of CD8 T cells in primary Chlamydia infection. Infect Immun 63:516-521, 1995
37. Buzoni-Gatel D, Guilloteau L, Bernard F, Bernard S, Chardes T, Rocca A: Protection against Chlamydia psittaci in mice conferred by Lyt-2+ T cells. Immunology 77:284-288, 1992
38. Starnbach NM, Bevan MJ, Lampe MF: Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol 153:5183-5199, 1994
39. Hassell AB, Pilling D, Reynolds D, Life PF, Bacon PA, Gaston JS: MHC restriction of synovial fluid lymphocyte responses to the triggering organism in reactive arthritis: absence of a class I-restricted response. Clin Exp Immunol 88:442-447, 1992
40. Engelhard V, Lacy E, Ridge JP: Influenza A specific, HLA-A2.1 restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of Ml protein. J Immunol 146:1226-1232, 1991
41. Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, Berzofsky JA: CTL response of HLA-A2.1 transgenic mice specific for hepatitis C viral peptides predict cpitopes for CTL of humans carrying HLA-A2.1. J Immunol 154:2733-2742, 1995
42. Bernard EJ, Le AXT, Barbosa JA, Lacy E, Engelhard VH: Cytotoxic T lymphocytes from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells. J Exp Med 168:1157-1162, 1988
43. Vitiello A, Marchesini D, Furze J, Sherman LA, Chestnut RW: Analysis of the HLA-rcstricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J Exp Med 173:1007-1015, 1991
44. Falk K, Rötzschke O, Rammensee HG: Specificity of antigen processing for MHC class I restricted presentation is conserved between mouse and man. Eur J Immunol 22:1323-1326, 1992
45. k) revealed by xenoreactive T lymphocytes. Eur J Immunol 23:338-342, 1993
46. Tussey LG, Rowland-Jones S, Zheng TS, Androlewicz MJ, Cresswell P, Frelinger JA, McMichael AJ: Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity 3:65-77, 1995
47. Rahman MU, Cheema MA, Schumacher HR, Hudson HP: Molecular evidence for the presence of chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum 35:521-529, 1992
48. Daser A, Urlaub H, Henklein P: HLA-B27 binding peptides derived from the 57 kD heat shock protein of Chlamydia trachomatis: novel insights into the peptide binding rules. Mol Immunol 31:331-336, 1994
49. Mescher MF: Surface contact requirements for activation of cytotoxic T lymphocytes. J Immunol 149:2402-2405, 1992
50. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL: Efficient major histocompatibility complex class 1 presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A 90:4942-4946, 1993
51. Rock KL: A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today 17:131-137, 1996
52. Nickerson CL, Hanson J, David CS: Expression of HLA-B27 in transgenic mice is dependent on the mouse H-2D genes. J Exp Med 172:1255-1261, 1990
53. Nickerson CL, Luthra HS, David CS: Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice. Ann Rheum Dis 49:426-433, 1990
54. 2microglobulin. J Immunol 141:4020-4023, 1988
55. Kalinke U, Arnold B, Hämmerling GJ: Strong xenogeneic HLA response in transgenic mice after introducing an α3 domain into HLA-B27. Nature 348:642-644, 1990
56. Ismail N, Chamberlain J, Inman RD: Persistence and dissemination of Yersinia enterocolitica 0:8 after intragastric challenge in B27-transgenic mice (abstract). Arthritis Rheum 37 (suppl 9): S211, 1994
57. Weinreich S, Eulderink F, Capkova J, Pla M, Gaede K, Heesemann J, van Alphen L, Zurcher C, Hoebe-Hewryk B, Kievits F, Ivanyi P: HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice. Hum Immunol 42:103-115, 1995
58. 2-microglobulin: a model of human spondyloarthropathies. J Exp Med 182:1153-1158, 1995
59. Madden DR, Gorga JC, Strominger JL, Wiley DC: The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353:321-325, 1991
60. Tanigaki N, Fruci D, Vigneti E, Staraca G, Roverso P, Londei M, Butler RH, Tosi R: The peptide binding specificity of HLA-B27 subtypes. Immunogenetics 40:192-198, 1994
61. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee HG: Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290-296, 1991
62. Wucherpfennig KW, Strominger JL: Molecular mimicry in T cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705, 1995